Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingfeng Chen

Showing results (231-240 of 253) with videos related to

Pageof 26
Sort By:
Frontiers in Immunology|August 29, 2022
Development of <i>RAG2</i> <sup>-/-</sup> <i>IL2Rγ</i> <sup>-/Y</sup> immune deficient FAH-knockout miniature pigHeng Zhao, Weijian Ye, Jianxiong Guo, et al.
Nature Communications|July 15, 2022
Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapyShijun Ma, Yue Zhao, Wee Chyan Lee, et al.
Nature Communications|February 2, 2023
G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinomaMaxine S Y Lam, Jose Antonio Reales-Calderon, Jin Rong Ow, et al.
Cell Stem Cell|July 16, 2019
Generation of Human PSC-Derived Kidney Organoids with Patterned Nephron Segments and a De Novo Vascular NetworkJian Hui Low, Pin Li, Elaine Guo Yan Chew, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2022
IFI16-dependent STING signaling is a crucial regulator of anti-HER2 immune response in HER2+ breast cancerLi-Teng Ong, Wee Chyan Lee, Shijun Ma, et al.
Science Advances|November 23, 2022
Successful targeting of PD-1/PD-L1 with chimeric antigen receptor-natural killer cells and nivolumab in a humanized mouse cancer modelWai Nam Liu, Wing Yan So, Sarah L Harden, et al.
Hepatology (Baltimore, Md.)|March 19, 2021
Analysis and Validation of Human Targets and Treatments Using a Hepatocellular Carcinoma-Immune Humanized Mouse ModelYue Zhao, Jiaxu Wang, Wai Nam Liu, et al.
Protein & Cell|January 11, 2018
Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENsYi Yang, Han Wu, Xiangjin Kang, et al.
Gut|July 8, 2015
Characterisation of liver pathogenesis, human immune responses and drug testing in a humanised mouse model of HCV infectionChoong Tat Keng, Ching Wooen Sze, Dahai Zheng, et al.
Scientific Reports|March 18, 2018
Bat-mouse bone marrow chimera: a novel animal model for dissecting the uniqueness of the bat immune systemKylie Su Mei Yong, Justin Han Jia Ng, Zhisheng Her, et al.
Pageof 26

Showing results (231-240 of 253) with videos related to

Sort By:
Pageof 26
Frontiers in Immunology|August 29, 2022
Development of <i>RAG2</i> <sup>-/-</sup> <i>IL2Rγ</i> <sup>-/Y</sup> immune deficient FAH-knockout miniature pigHeng Zhao, Weijian Ye, Jianxiong Guo, et al.
Nature Communications|July 15, 2022
Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapyShijun Ma, Yue Zhao, Wee Chyan Lee, et al.
Nature Communications|February 2, 2023
G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinomaMaxine S Y Lam, Jose Antonio Reales-Calderon, Jin Rong Ow, et al.
Cell Stem Cell|July 16, 2019
Generation of Human PSC-Derived Kidney Organoids with Patterned Nephron Segments and a De Novo Vascular NetworkJian Hui Low, Pin Li, Elaine Guo Yan Chew, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2022
IFI16-dependent STING signaling is a crucial regulator of anti-HER2 immune response in HER2+ breast cancerLi-Teng Ong, Wee Chyan Lee, Shijun Ma, et al.
Science Advances|November 23, 2022
Successful targeting of PD-1/PD-L1 with chimeric antigen receptor-natural killer cells and nivolumab in a humanized mouse cancer modelWai Nam Liu, Wing Yan So, Sarah L Harden, et al.
Hepatology (Baltimore, Md.)|March 19, 2021
Analysis and Validation of Human Targets and Treatments Using a Hepatocellular Carcinoma-Immune Humanized Mouse ModelYue Zhao, Jiaxu Wang, Wai Nam Liu, et al.
Protein & Cell|January 11, 2018
Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENsYi Yang, Han Wu, Xiangjin Kang, et al.
Gut|July 8, 2015
Characterisation of liver pathogenesis, human immune responses and drug testing in a humanised mouse model of HCV infectionChoong Tat Keng, Ching Wooen Sze, Dahai Zheng, et al.
Scientific Reports|March 18, 2018
Bat-mouse bone marrow chimera: a novel animal model for dissecting the uniqueness of the bat immune systemKylie Su Mei Yong, Justin Han Jia Ng, Zhisheng Her, et al.
Pageof 26